Assessment of the MDA and MDMA optical isomers in a stimulant-hallucinogen discrimination. (Q51538484)

6 April 2018

MDMA

0 references

title

Assessment of the MDA and MDMA optical isomers in a stimulant-hallucinogen discrimination. (English)

1 reference

6 April 2018

author name string

Baker LE

series ordinal

1

1 reference

6 April 2018

Taylor MM

series ordinal

2

1 reference

6 April 2018

language of work or name

English

0 references

publication date

1 August 1997

1 reference

6 April 2018

Pharmacology, Biochemistry and Behavior

published in

1 reference

6 April 2018

volume

57

1 reference

6 April 2018

issue

4

1 reference

6 April 2018

page(s)

737-748

1 reference

6 April 2018

Ecstacy: a review of MDMA and MDA.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900334-6

7 January 2021

Three-choice discrimination among (+)-amphetamine, fenfluramine and saline in pigeons.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900334-6

7 January 2021

Further investigation of the discriminative stimulus properties of MDA.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900334-6

7 January 2021

Stimulus properties of 1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDA) analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900334-6

7 January 2021

Enantiomeric differences in the effects of 3,4-methylenedioxymethamphetamine on extracellular monoamines and metabolites in the striatum of freely-moving rats: An in vivo microdialysis study

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900334-6

7 January 2021

The effect of optical isomers of 3,4-methylenedioxymethamphetamine (MDMA) on stereotyped behavior in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900334-6

7 January 2021

Effects of the enantiomers of MDA, MDMA and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slices

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900334-6

7 January 2021

3,4-Methylenedioxymethamphetamine (MDMA): stereoselective interactions at brain 5-HT1 and 5-HT2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900334-6

7 January 2021

3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential effects on synaptosomal release of 3H-dopamine and 3H-5-hydroxytryptamine

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900334-6

7 January 2021

Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: representatives of a novel therapeutic class.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900334-6

7 January 2021

Drug discrimination studies with MDMA and amphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900334-6

7 January 2021

The effect of MDA and MDMA ("Ecstasy") isomers in combination with pirenpirone on operant responding in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900334-6

7 January 2021

Discriminative profile of MDMA.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900334-6

7 January 2021

Serotonergic-dopaminergic mediation of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900334-6

7 January 2021

In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900334-6

7 January 2021

Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900334-6

7 January 2021

The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900334-6

7 January 2021

10.1016/S0091-3057(96)00334-6

Identifiers

DOI

1 reference

6 April 2018

PubMed ID

9259001

1 reference

6 April 2018